Outcome

The study investigated the safety and effectiveness of low-pressure hyperbaric oxygen therapy (HBOT) at 1.5 ATA for military subjects with mild to moderate traumatic brain injury (TBI) post-concussion syndrome (PCS) and post-traumatic stress disorder (PTSD). Sixteen subjects received 40 HBOT sessions in 30 days.

Introduction

In a groundbreaking study researchers have explored the potential of low-pressure hyperbaric oxygen therapy (HBOT) to aid military personnel suffering from chronic blast-induced traumatic brain injury (TBI) post-concussion syndrome (PCS) and post-traumatic stress disorder (PTSD). Sixteen military subjects underwent a ‘typical dose’ of 40 sessions at 1.5 atmospheres absolute (ATA) for 60 minutes each within 30 days. The findings revealed significant improvements in cognitive function including a notable increase in full-scale IQ and reductions in symptoms of depression anxiety and PTSD. Neuropsychological and physical exams affirmed these benefits showing enhanced memory attention and executive function. Moreover SPECT imaging demonstrated remarkable improvements in cerebral blood flow affirming the physiological benefits of the treatment. This study underscores the potential of HBOT in improving the quality of life and cognitive abilities of those suffering from blast-induced brain injuries and associated disorders marking a promising step towards effective treatment options for these challenging conditions.

Results

The study investigated the effects of 1.5 ATA hyperbaric oxygen therapy (HBOT) on military subjects with blast-induced mild to moderate traumatic brain injury (TBI) post-concussion syndrome (PCS) and post-traumatic stress disorder (PTSD). Sixteen military subjects underwent 40 HBOT sessions each lasting 60 minutes over 30 days. The results showed significant improvement in various areas.

Subjects experienced marked symptoms relief better neurological exams and higher cognitive testing scores. Specific gains included a 14.8 point increase in full-scale IQ and significant improvements in memory and attention as measured by the WMS-IV (Working Memory and Delayed Memory tests) the Stroop Test and other cognitive assessments. Notable improvements were also seen in behavior and mood with reductions in impulsivity PCS and PTSD symptoms. Depression and anxiety levels as measured by the PHQ-9 and GAD-7 scales decreased significantly.

Quality of life scores rose markedly and self-reported normalcy percentages improved. SPECT brain scans showed marked improvements in brain blood flow after both the first and the 40th HBOT session with significant changes noted in white and grey matter.

Overall the study concludes that 1.5 ATA HBOT is safe and effective for treating blast-induced PCS and PTSD in military subjects. It led to substantial improvements in symptoms quality of life cognitive function and brain blood flow.

Conclusion

The conclusion of this study underscores the promising impact of low-pressure hyperbaric oxygen therapy (HBOT) on military subjects suffering from chronic blast-induced mild to moderate traumatic brain injury (TBI) post-concussion syndrome (PCS) and post-traumatic stress disorder (PTSD). Throughout the 40 sessions of 1.5 ATA HBOT administered over 30 days subjects displayed significant improvements in cognitive function including full-scale IQ memory and attention as well as notable reductions in PCS and PTSD symptoms depression and anxiety. Quality of life scores also significantly improved and subjects reported a higher self-assessment of normalcy.

Remarkably the study reported significant enhancements in cerebral blood flow evidenced by SPECT imaging after the first and 40th HBOT sessions. These findings not only showcase the efficacy of HBOT in alleviating neurological and psychological symptoms but also highlight its potential to improve overall brain function in individuals with chronic blast-induced injuries. This phase I study indicates that HBOT is a safe and effective therapeutic approach offering a glimmer of hope for improving the well-being and cognitive health of military personnel affected by TBI PCS and PTSD. Further research with larger cohorts is warranted to confirm these encouraging results and to explore the broader implications of HBOT as a treatment for such conditions.